Kaon-CL 20% Side Effects
Generic name: potassium chloride
Medically reviewed by Drugs.com. Last updated on Nov 4, 2022.
Note: This document contains side effect information about potassium chloride. Some dosage forms listed on this page may not apply to the brand name Kaon-CL 20%.
Applies to potassium chloride: oral tablet extended release. Other dosage forms:
Serious side effects of Kaon-CL 20%
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:
- Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
- Signs of a high potassium level like a heartbeat that does not feel normal; change in thinking clearly and with logic; feeling weak, lightheaded, or dizzy; feel like passing out; numbness or tingling; or shortness of breath.
- Slow heartbeat.
- Chest pain or pressure.
- Signs of bowel problems like black, tarry, or bloody stools; fever; mucus in the stools; throwing up blood or throw up that looks like coffee grounds; or very bad stomach pain, constipation, or diarrhea.
- Swelling of belly.
Other side effects of Kaon-CL 20%
All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away:
- Stomach pain or diarrhea.
- Upset stomach or throwing up.
- Some products of potassium are in a wax matrix; you may see this in stool. The potassium has been taken into the body, but the wax has not.
These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at 1-800-332-1088. You may also report side effects at https://www.fda.gov/medwatch.
For Healthcare Professionals
Applies to potassium chloride: compounding powder, intravenous solution, oral capsule extended release, oral granule extended release, oral liquid, oral powder for reconstitution, oral tablet, oral tablet extended release.
Hyperkalemia can cause muscle weakness, paresthesia of the extremities, listlessness, mental confusion, flaccid paralysis, cold skin, grey pallor, peripheral vascular collapse, fall in blood pressure, paralysis, cardiac arrhythmias, and heart block. Electrocardiogram abnormalities include disappearance of the P-wave, widening and slurring of QRS complex, changes of the S-T segment, tall peaked T-waves. At extremely high concentrations (8 to 11 mmol/L) may cause death from cardiac depression, arrhythmias, or arrest.[Ref]
Postmarketing reports: Delayed intestinal transit[Ref]
Frequency not reported: Injection site pain, injection site phlebitis, infection at injection site, venous thrombosis extending from site of injection, extravasation[Ref]
Frequency not reported: Cardiac arrhythmias, cardiac arrest[Ref]
Rare (less than 0.1%): Skin rash
Frequency not reported: Febrile response[Ref]
More about Kaon-CL 20% (potassium chloride)
Related treatment guides
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum, Inc. "Australian Product Information." O 0
3. "Product Information. Klor-Con M10 (potassium chloride)." Upsher-Smith Laboratories Inc (2016):
4. "Product Information. Potassium Chloride (potassium chloride)." Pharmaceutical Assoc Inc Div Beach Products (2016):
5. "Product Information. Potassium Chloride In Dextrose and S (LVP solution with potassium)." B Braun Medical Inc, Irvine, CA.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.